{"id":28320,"date":"2024-10-24T21:18:24","date_gmt":"2024-10-24T20:18:24","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=28320"},"modified":"2024-10-24T21:18:24","modified_gmt":"2024-10-24T20:18:24","slug":"ingiltere-alzheimer-ilaci-icin-devlet-odemesi-yapmayacak","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/ingiltere-alzheimer-ilaci-icin-devlet-odemesi-yapmayacak\/","title":{"rendered":"\u0130ngiltere, Alzheimer \u0130lac\u0131 \u0130\u00e7in Devlet \u00d6demesi Yapmayacak"},"content":{"rendered":"

\u0130ngiltere\u2019de onaylanan yeni bir Alzheimer ilac\u0131 olan Kisunla, ba\u011f\u0131ms\u0131z bir g\u00f6zlemci kurumun ilac\u0131n maliyetini vergi m\u00fckelleflerine y\u00fcklemenin uygun olmayaca\u011f\u0131 y\u00f6n\u00fcndeki a\u00e7\u0131klamas\u0131n\u0131n ard\u0131ndan devlet taraf\u0131ndan finanse edilmeyecek. \u0130ngiltere Ulusal Sa\u011fl\u0131k ve Bak\u0131m M\u00fckemmelli\u011fi Enstit\u00fcs\u00fc (NICE), Kisunla’n\u0131n etkisini tam olarak kan\u0131tlamak i\u00e7in daha fazla ara\u015ft\u0131rmaya ihtiya\u00e7 oldu\u011funu belirtti.<\/p>\n

A\u011fustos ay\u0131nda onaylanan ilk Alzheimer ilac\u0131 Leqembi de benzer bir duruma maruz kalm\u0131\u015ft\u0131. Ayn\u0131 g\u00f6zlemci kurum, bu ilac\u0131n da Ulusal Sa\u011fl\u0131k Hizmeti (NHS) taraf\u0131ndan sat\u0131n al\u0131nmamas\u0131 gerekti\u011fini tavsiye etmi\u015fti.<\/p>\n

NICE’in a\u00e7\u0131klamas\u0131na g\u00f6re, Kisunla\u2019n\u0131n Alzheimer hastal\u0131\u011f\u0131n\u0131n ilerlemesini yava\u015flatmada baz\u0131 etkiler g\u00f6sterdi\u011fi g\u00f6zlemlenmi\u015f olsa da, ila\u00e7 i\u00e7in bir y\u0131ll\u0131k tedavi maliyetinin 32.000 dolar (yakla\u015f\u0131k 1 milyon TL) olmas\u0131, tedavinin yayg\u0131n kullan\u0131m\u0131n\u0131 k\u0131s\u0131tlayan en \u00f6nemli fakt\u00f6rlerden biri olarak g\u00f6sterildi.<\/p>

\"\"<\/a><\/div>\n

Kisunla, Alzheimer hastal\u0131\u011f\u0131na neden oldu\u011funa inan\u0131lan yap\u0131\u015fkan bir proteini beyinden uzakla\u015ft\u0131rarak hastal\u0131\u011f\u0131n \u00f6n\u00fcne ge\u00e7meyi hedefleyen bir tedavi olarak geli\u015ftirildi. \u0130la\u00e7, hastal\u0131\u011f\u0131n erken evrelerinde kullan\u0131lmas\u0131 i\u00e7in onaylanm\u0131\u015f olsa da, NICE ilac\u0131n maliyetine de\u011fip de\u011fmeyece\u011fi konusunda \u015f\u00fcphelerini dile getirdi.<\/p>\n

Euronews\u2019un haberine g\u00f6re, ila\u00e7 \u00fcreticisi Eli Lilly, ilac\u0131n maliyetine y\u00f6nelik ele\u015ftiriler kar\u015f\u0131s\u0131nda, ilac\u0131n uzun vadede hastalar i\u00e7in \u00f6nemli bir fark yarataca\u011f\u0131n\u0131 savundu.<\/p>\n

\"\"<\/a><\/div>","protected":false},"excerpt":{"rendered":"

\u0130ngiltere\u2019de onaylanan yeni bir Alzheimer ilac\u0131 olan Kisunla, ba\u011f\u0131ms\u0131z bir g\u00f6zlemci kurumun ilac\u0131n maliyetini vergi m\u00fckelleflerine y\u00fcklemenin uygun olmayaca\u011f\u0131 y\u00f6n\u00fcndeki a\u00e7\u0131klamas\u0131n\u0131n ard\u0131ndan devlet taraf\u0131ndan finanse edilmeyecek. \u0130ngiltere Ulusal Sa\u011fl\u0131k ve Bak\u0131m M\u00fckemmelli\u011fi Enstit\u00fcs\u00fc (NICE), Kisunla’n\u0131n etkisini tam olarak kan\u0131tlamak i\u00e7in daha fazla ara\u015ft\u0131rmaya ihtiya\u00e7 oldu\u011funu belirtti. A\u011fustos ay\u0131nda onaylanan ilk Alzheimer ilac\u0131 Leqembi de benzer bir duruma maruz kalm\u0131\u015ft\u0131. Ayn\u0131 g\u00f6zlemci kurum, bu ilac\u0131n da Ulusal Sa\u011fl\u0131k Hizmeti (NHS) taraf\u0131ndan sat\u0131n al\u0131nmamas\u0131 gerekti\u011fini tavsiye etmi\u015fti. NICE’in a\u00e7\u0131klamas\u0131na g\u00f6re, Kisunla\u2019n\u0131n Alzheimer hastal\u0131\u011f\u0131n\u0131n ilerlemesini yava\u015flatmada baz\u0131 etkiler g\u00f6sterdi\u011fi g\u00f6zlemlenmi\u015f olsa da, ila\u00e7 i\u00e7in bir y\u0131ll\u0131k tedavi maliyetinin 32.000 dolar (yakla\u015f\u0131k 1 milyon […]<\/p>\n","protected":false},"author":1,"featured_media":28321,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[5269],"tags":[],"class_list":["post-28320","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-birlesik-krallik"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/28320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=28320"}],"version-history":[{"count":0,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/28320\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media\/28321"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=28320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=28320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=28320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}